Publications
5808 Results
- Journal / Conference
- Blood 122:356, 2013; American Society of Hematology annual meeting (Dec 7-10, 2013, New Orleans, LA), oral;
- Year
- 2013
- Research Committee(s)
- Leukemia
- PMID
- n/a
- PMC
- n/a
- Study Number(s)
- S0106
The addition of gemtuzumab ozogamicin (GO) to induction chemotherapy reduces relapse and improves survival in patients without adverse risk karyotype: results of an individual patient meta-analysis of the five randomised trials
- Journal / Conference
- Blood 122:3060; American Society of Hematology annual meeting (Dec 7-10, 2013), poster;
- Year
- 2013
- Research Committee(s)
- Lymphoma
- Study Number(s)
- E2496, E4494
The role of body mass index in survival outcome for lymphoma patients: an Eastern Cooperative Oncology Group Experience
- Journal / Conference
- Blood 122:1383; American Society of Hematology annual meeting (Dec 7-10, 2013, New Orleans, LA), poster;
- Year
- 2013
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106, S0112, S0301, S0325, S0333, S0432, S0521, S0530, S0535, S0605, S0703
Alteration of cytogenetic risk stratification in new diagnosis of leukemia by FISH testing - the SWOG experience
- Journal / Conference
- Blood 122:2686; American Society of Hematology annual meeting (Dec 7-10, 2013, New Orleans, LA), poster;
- Year
- 2013
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106, SWOG-9031, SWOG-9333, SWOG-9500
Impact of cytarabine dose in the induction regimen on the outcome of patients with newly diagnosed acute myeloid leukemia with or without NPM1 and/or FLT3 mutations: A SWOG and MD Anderson Cancer Center Report
- Journal / Conference
- Blood 122:488; American Society of Hematology annual meeting (Dec 7-10, 2013, New Orleans, LA), oral;
- Year
- 2013
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106
NUP98/NSD1 translocation further risk-stratifies patients with FLT3/ITD in acute myeloid leukemia: A report from Children’s Oncology Group and SWOG
- Journal / Conference
- Blood 122:1315; American Society of Hematology annual meeting (Dec 7-10, New Orleans, LA), poster;
- Year
- 2013
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106, SWOG-9031, SWOG-9333, SWOG-9500
Prognostic significance of NPM1 mutations in the absence of FLT3-ITD in older patients with AML: a SWOG report
- Journal / Conference
- Nutrients 5(4):1122-1148
- Year
- 2013
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID23552052
- PMC
- PMC3705339
- Study Number(s)
- S0000
Selenium and prostate cancer prevention: insights from the selenium and vitamin E cancer prevention trial (SELECT)
- Journal / Conference
- Journal of Clinical Oncology 31(3):373-379
- Year
- 2013
- Research Committee(s)
- Melanoma
- PMID
- PMID23248256
- PMC
- PMC4878104
- Study Number(s)
- CTSU/E2603
Phase III trial of carboplatin and paclitaxel with or without sorafenib in metastatic melanoma
- Journal / Conference
- Journal of Clinical Oncology 31(18):2347-2357
- Year
- 2013
- Research Committee(s)
- Myeloma
- PMID
- PMID23690408
- PMC
- PMC Journal - In process
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease
- Journal / Conference
- Clinical Cancer Research 19(20):5798-5807;
- Year
- 2013
- Research Committee(s)
- Breast
- PMID
- PMID23965903
- PMC
- PMC3805021
- Study Number(s)
- N9831